Clinical Trial Update: Cannabidiol for Inflammatory Bowel Disease [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating cannabidiol for inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Meir Medical Center | Conditions: Crohn's Disease, Ulcerative Colitis | Phase 1, Phase 2 | Status: COMPLETED